Therapeutic Area | MeSH |
---|---|
nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NIKITA | Lupin Research | N-209875 DISCN | 2017-08-04 | 3 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
livalo | New Drug Application | 2024-09-03 |
nikita | New Drug Application | 2023-06-30 |
pitavastatin | ANDA | 2025-02-04 |
pitavastatin calcium | ANDA | 2024-12-03 |
zypitamag | New Drug Application | 2025-01-01 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypercholesterolemia | — | D006937 | — |
hypertriglyceridemia | EFO_0004211 | D015228 | — |
hyperlipoproteinemias | — | D006951 | — |
Expiration | Code | ||
---|---|---|---|
PITAVASTATIN CALCIUM, PITAVASTATIN CALCIUM, AUROBINDO PHARMA | |||
2024-02-19 | PC |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypercholesterolemia | D006937 | — | — | — | — | 2 | — | — | 2 |
Dyslipidemias | D050171 | — | — | — | — | 1 | — | — | 1 |
Drug common name | Pitavastatin |
INN | pitavastatin |
Description | Pitavastatin is a dihydroxy monocarboxylic acid that is (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]hept-6-enoic acid in which the two hydroxy groups are located at positions 3 and 5 (the 3R,5S-stereoisomer). Used as its calcium salt for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise. It has a role as an antioxidant. It is a member of quinolines, a dihydroxy monocarboxylic acid, a member of cyclopropanes, a statin (synthetic) and a member of monofluorobenzenes. It is a conjugate acid of a pitavastatin(1-). |
Classification | Small molecule |
Drug class | enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1 |
PDB | — |
CAS-ID | 147511-69-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1201753 |
ChEBI ID | 32020 |
PubChem CID | 5282452 |
DrugBank | — |
UNII ID | M5681Q5F9P (ChemIDplus, GSRS) |